96 related articles for article (PubMed ID: 6401595)
1. Correlation of hypercupremia with other acute phase reactants in malignant lymphoma.
Shah I; Lewkow LM; Khilanani U
Cancer; 1983 Mar; 51(5):851-4. PubMed ID: 6401595
[TBL] [Abstract][Full Text] [Related]
2. Serum copper levels in non-Hodgkin's lymphoma.
Shah-Reddy I; Khilanani P; Bishop CR
Cancer; 1980 Apr; 45(8):2156-9. PubMed ID: 6989485
[TBL] [Abstract][Full Text] [Related]
3. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
[TBL] [Abstract][Full Text] [Related]
4. Role of sialyltransferase in hypercupraemia of non-Hodgkin's lymphoma.
Shah I; Chou T; Tapazoglou E; Kessel D
Scand J Haematol; 1984 Mar; 32(3):332-4. PubMed ID: 6701469
[TBL] [Abstract][Full Text] [Related]
5. Serum copper and zinc levels and copper/zinc ratio in pediatric non-Hodgkin's lymphoma.
Gözdaşoğlu S; Cavdar AO; Arcasoy A; Akar N
Acta Haematol; 1982; 67(1):67-70. PubMed ID: 6800204
[TBL] [Abstract][Full Text] [Related]
6. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
7. Alterations of plasma levels in malignant lymphoma.
Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
[TBL] [Abstract][Full Text] [Related]
8. The value of serum copper levels in non-Hodgkin's lymphoma.
Cohen Y; Epelbaum R; Haim N; McShan D; Zinder O
Cancer; 1984 Jan; 53(2):296-300. PubMed ID: 6690011
[TBL] [Abstract][Full Text] [Related]
9. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
Sirsat AV; Raste AS; Talavdekar RV; Advani SH
Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
[No Abstract] [Full Text] [Related]
10. [Diagnostic value of copper, haptoglobin and alpha-2-globulin in the serum of patients with Hodgkin's disease].
Cepelja Z; Grgić Z; Markinković M; Ivanov D
Lijec Vjesn; 1975 May; 97(5):289-93. PubMed ID: 54857
[No Abstract] [Full Text] [Related]
11. [Changes in the factor VIII molecular complex in Hodgkin's disease and non-Hodgkin's lymphoma].
Lisichkov T; Tsekova R
Vutr Boles; 1987; 26(3):69-71. PubMed ID: 3113078
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of serum copper levels and other hematochemical parameters in malignancies.
Pizzolo G; Savarin T; Molino AM; Ambrosetti A; Todeschini G; Vettore L
Tumori; 1978 Feb; 64(1):55-61. PubMed ID: 77579
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
Casamassima A; Addabbo L; Caporusso L; Lorusso V
Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
[TBL] [Abstract][Full Text] [Related]
14. Serum copper level in non-Hodgkin's lymphomas.
Salvagno L; Pappagallo GL; Chiarion Sileni V; Segati R; Cartei G; Endrizzi L; Paccagnella A; Ongaro G; Bonvicini P; Fiorentino MV
Tumori; 1982 Feb; 68(1):57-62. PubMed ID: 7071946
[TBL] [Abstract][Full Text] [Related]
15. Serum haptoglobin level in patients with malignant lymphoma and its clinical significance.
Desai SS; Ishwad CS; Balakrishnan V; Naik SN
Indian J Cancer; 1990 Mar; 27(1):46-54. PubMed ID: 2391130
[TBL] [Abstract][Full Text] [Related]
16. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
[No Abstract] [Full Text] [Related]
17. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
[TBL] [Abstract][Full Text] [Related]
18. Serum copper observations in patients with malignant lymphoma.
Hrgovcic M; Tessmer CF; Thomas FB; Ong PS; Gamble JF; Shullenberger CC
Cancer; 1973 Dec; 32(6):1512-24. PubMed ID: 4757937
[No Abstract] [Full Text] [Related]
19. Metabolic changes in red blood cells in malignant lymphomas.
De Bellis R; Boulard MR; Kasdorf H; Rodriguez I; Ferrando R; Di Landro J; Ferrari M; Sanguinett CM; Tanzer J
Br J Haematol; 1979 May; 42(1):35-9. PubMed ID: 465359
[TBL] [Abstract][Full Text] [Related]
20. [Factors of the "acute phase" in proliferative diseases of the hemopoietic system].
Szela S
Wiad Lek; 1992 Sep; 45(17-18):659-64. PubMed ID: 1295250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
